期刊文献+

H9N2亚型禽流感病毒在MDCK细胞中增殖最佳条件研究 被引量:5

Study on Optimal Proliferation of H9N2 Avian Influenza Virus in MDCK Cells
下载PDF
导出
摘要 为了探讨H9N2亚型禽流感病毒在MDCK细胞中增殖的最佳条件,将不同毒株、不同接种量的H9N2亚型禽流感病毒接种MDCK细胞单层,接毒后直接加入或吸附1h后加入含有10μg/mL胰蛋白酶的DMEM维持液,每隔24h观察细胞病变,并测定细胞上清液中HA滴度。结果表明,分离株HN04在MDCK细胞中增殖能力较其他2株强,接种后72h可达到6log2;病毒接种细胞的最佳稀释度为103~104之间;病毒接种细胞后吸附与否对病毒滴度无显著差异。 This study aimed to determine the optimal proliferation conditions of H9N2 avian influenza virus in MDCK cells.The proliferation ability of H9N2 avian influenza virus in MDCK cells was evaluated by using different isolates,different inoculation doses,and pre-adsorption for 1 h or non-adsorption in DMEM medium containing 10 μg/mL trypsin.The cytopathic effect(CPE) of MDCK was observed every 24 h,and the HA titer of the supernatant was measured by HA assay.Result showed that the isolate of HN04 showed a little higher HA titer than the other two isolates.The highest HA titer reached 6log2 at 72 h after inoculation.The optimal dilution was 103-104 for all isolates.No significant difference was observed between pre-adsorption for 1 h and non-adsorption.
出处 《动物医学进展》 CSCD 北大核心 2011年第11期42-45,共4页 Progress In Veterinary Medicine
基金 北京市农林科学院一般项目(2010A007)
关键词 禽流感病毒 H9N2亚型 MDCK细胞 增殖 Avian influenza virus H9N2 subtype MDCK cell proliferation
  • 相关文献

参考文献15

  • 1毕英佐.H9N2亚型禽流感的流行现状和防制措施[J].中国家禽,2009,31(11):33-34. 被引量:23
  • 2姜北宇,章振华,李林,景小冬,张建伟,郑小兰.禽流感H9亚型流行毒株交叉免疫保护试验[J].动物医学进展,2009,30(8):29-33. 被引量:17
  • 3周蛟.世界主要禽病流行现状[J].中国家禽,2007,29(6):1-4. 被引量:9
  • 4叶柱德,胡江锋.H9N2亚型禽流感病毒疫苗研究进展[J].动物医学进展,2008,29(2):89-92. 被引量:10
  • 5Kistner O,Barrett P N,Mundt W,el al. Development of a mat malian cell (Veto) derived candidate influenza virus vaect[J]. Vaccine, 1998, 16(9-10): 960-968.
  • 6Makizumi K, Kimachi K, Fukada K, et al. Timely production of A/Fujian-like influenza vaccine matching the 2003-2004 epidemic strain may have been possible using Madin-Darhy canine kidney cells [J]. Vaccine, 2008, 26: 6852-6858.
  • 7Lohr V, Genzel Y, Behrendt I, et al. A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor[J]. Vaccine, 2010,28 : 62560-6264.
  • 8Youil R, Su Q, Toner T J, et al. Comparative study of influenza virus replication in Veto and MDCK cell lines [J]. J Virol Meth, 2004, 120(1): 23-31.
  • 9Halperin S. A, Smith B, Mabrouk T, et al. Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture derived influenza vaccine in healthy adults, seniors, and children [J]. Vaccine, 2002, 20(7-8): 1240-1247.
  • 10Liu J, Shi X, Schwartz R, et al. Use of MDCK cells for production of live attenuated influenza vaccine [J]. Vaccine, 2009 (27) : 6460-6463.

二级参考文献76

共引文献98

同被引文献62

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部